A Phase 1 Study of OTS-412 (Recombinant Oncolytic Vaccinia Virus) in Treatment-refractory Solid Tumor Patients (South Korea)

Clinical trial NCT07190833 · RECRUITING

Trial details

NCT number: NCT07190833
Sponsor: Bionoxx Inc.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Treatment-Refractory Solid Tumors

Start date: 2026-03-09
Primary completion: 2028-12-01
Enrollment: 27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.